Four manuscripts addressed downregulation of antigen presentation in IDH‐mutant gliomas, either by downregulation of MHC molecules of tumor cells in two manuscripts or lower TMB of IDH‐mutant gliomas in three papers, with one of the latter being one of the formerly mentioned two manuscripts. The gene discussed is IDH2; the disease is central nervous system cancer.